By Nancy Walsh, Staff Writer, MedPage TodayPublished: March 28, 2012Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston.
Take Posttest
Action Points
Targeting the interleukin (IL)-17 signaling pathway may provide an effective and specific treatment approach for patients with moderate-to-severe plaque psoriasis, two multicenter randomized phase II
No comments:
Post a Comment